PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
1,411,795
Share change
-67,640
Total reported value
$6,927,008
Price per share
$4.91
Number of holders
21
Value change
-$367,485
Number of buys
7
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q4 2022

As of 31 Dec 2022, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,411,795 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, RBF Capital, LLC, BlackRock Inc., CANNELL CAPITAL LLC, Ancora Advisors, LLC, DIMENSIONAL FUND ADVISORS LP, WEALTH EFFECTS LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.